INOVA and George Mason University formed a partnership to conduct translational research. The partnership was announced by Virginia Gov. Terry McAuliffe.
“By combining resources, Inova and Mason will place Virginia at the forefront of the fight against cancer, heart disease and other life-threatening illnesses,” said McAuliffe. “Biomedical research is also a pillar of the ‘New Virginia Economy.’ The work these two great institutions perform will spur opportunities for entrepreneurship, create new companies and generate jobs that will grow our economy and help us prosper.”
The partnership will establish a Scientific Connector Facility and the Inova-Mason Proteomics Center. Both will be housed on the campus of the Inova Center for Personalized Health. Inova will have a physical presence on Mason’s Science and Technology Campus so its physicians and researchers can utilize Mason’s research capabilities and labs.
Mason and Inova will also establish a Personalized Medicine Public Policy and Ethics Institute, along with an endowed chair to support this initiative. The partnership will also include a fellowship program to recruit internationally recognized researchers and clinical investigators to both institutions.
